795 related articles for article (PubMed ID: 3066652)
1. Glucose disposal in obese non-diabetic and diabetic type II patients. A study by indirect calorimetry and euglycemic insulin clamp.
Golay A; Defronzo RA; Thorin D; Jequier E; Felber JP
Diabete Metab; 1988; 14(4):443-51. PubMed ID: 3066652
[TBL] [Abstract][Full Text] [Related]
2. Body fat mass distribution. Influence on metabolic and atherosclerotic parameters in non-insulin dependent diabetics and obese subjects with and without impaired glucose tolerance. Influence of weight reduction.
Van Gaal L
Verh K Acad Geneeskd Belg; 1989; 51(1):47-80. PubMed ID: 2800685
[TBL] [Abstract][Full Text] [Related]
3. [The effect of body weight on insulin activity].
Sindelka G; Skrha J; Prázný M; Hilgertová J
Vnitr Lek; 1999 Sep; 45(9):540-4. PubMed ID: 10951879
[TBL] [Abstract][Full Text] [Related]
4. Hepatic insulin resistance in obese non-diabetic subjects and in type 2 diabetic patients.
Paquot N; Scheen AJ; Dirlewanger M; Lefèbvre PJ; Tappy L
Obes Res; 2002 Mar; 10(3):129-34. PubMed ID: 11886934
[TBL] [Abstract][Full Text] [Related]
5. Insulin signalling in skeletal muscle of subjects with or without Type II-diabetes and first degree relatives of patients with the disease.
Meyer MM; Levin K; Grimmsmann T; Beck-Nielsen H; Klein HH
Diabetologia; 2002 Jun; 45(6):813-22. PubMed ID: 12107725
[TBL] [Abstract][Full Text] [Related]
6. Defective amplification of the late phase insulin response to glucose by GIP in obese Type II diabetic patients.
Vilsbøll T; Krarup T; Madsbad S; Holst JJ
Diabetologia; 2002 Aug; 45(8):1111-9. PubMed ID: 12189441
[TBL] [Abstract][Full Text] [Related]
7. Physical training in the prophylaxis and treatment of obesity, hypertension and diabetes.
Krotkiewski M
Scand J Rehabil Med Suppl; 1983; 9():55-70. PubMed ID: 6372078
[TBL] [Abstract][Full Text] [Related]
8. Effects of metformin treatment on erythrocyte insulin binding in normal weight subjects, in obese non diabetic subjects, in type 1 and type 2 diabetic patients.
Rizkalla SW; Elgrably F; Tchobroutsky G; Slama G
Diabete Metab; 1986 Aug; 12(4):219-24. PubMed ID: 3533670
[TBL] [Abstract][Full Text] [Related]
9. Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects.
Gastaldelli A; Cusi K; Pettiti M; Hardies J; Miyazaki Y; Berria R; Buzzigoli E; Sironi AM; Cersosimo E; Ferrannini E; Defronzo RA
Gastroenterology; 2007 Aug; 133(2):496-506. PubMed ID: 17681171
[TBL] [Abstract][Full Text] [Related]
10. Multiple disturbances of free fatty acid metabolism in noninsulin-dependent diabetes. Effect of oral hypoglycemic therapy.
Taskinen MR; Bogardus C; Kennedy A; Howard BV
J Clin Invest; 1985 Aug; 76(2):637-44. PubMed ID: 3897287
[TBL] [Abstract][Full Text] [Related]
11. Effect of obesity on susceptibility to fatty acid-induced peripheral tissue insulin resistance.
Kruszynska YT; Olefsky JM; Frias JP
Metabolism; 2003 Feb; 52(2):233-8. PubMed ID: 12601639
[TBL] [Abstract][Full Text] [Related]
12. Impact of obesity on insulin action in NIDDM.
Campbell PJ; Carlson MG
Diabetes; 1993 Mar; 42(3):405-10. PubMed ID: 8432411
[TBL] [Abstract][Full Text] [Related]
13. Glucose resistance contributes to diabetes mellitus in cirrhosis.
Petrides AS; Schulze-Berge D; Vogt C; Matthews DE; Strohmeyer G
Hepatology; 1993 Aug; 18(2):284-91. PubMed ID: 8340056
[TBL] [Abstract][Full Text] [Related]
14. Fibrinogen kinetics and protein turnover in obese non-diabetic males: effects of insulin.
Tessari P; Cosma A; Vettore M; Millioni R; Puricelli L; Cogo P; Cecchet D; Carnielli V; Kiwanuka E
Diabetes Metab Res Rev; 2010 Jan; 26(1):50-8. PubMed ID: 19943326
[TBL] [Abstract][Full Text] [Related]
15. Total body fat content and fat topography are associated differently with in vivo glucose metabolism in nonobese and obese nondiabetic women.
Bonora E; Del Prato S; Bonadonna RC; Gulli G; Solini A; Shank ML; Ghiatas AA; Lancaster JL; Kilcoyne RF; Alyassin AM
Diabetes; 1992 Sep; 41(9):1151-9. PubMed ID: 1499866
[TBL] [Abstract][Full Text] [Related]
16. Glucose and lipid metabolism in non-insulin-dependent diabetes. Effect of metformin.
Riccio A; Del Prato S; Vigili de Kreutzenberg S; Tiengo A
Diabete Metab; 1991 May; 17(1 Pt 2):180-4. PubMed ID: 1936473
[TBL] [Abstract][Full Text] [Related]
17. Reversibility of insulin resistance in obese diabetic patients: role of plasma lipids.
Mingrone G; DeGaetano A; Greco AV; Capristo E; Benedetti G; Castagneto M; Gasbarrini G
Diabetologia; 1997 May; 40(5):599-605. PubMed ID: 9165230
[TBL] [Abstract][Full Text] [Related]
18. Sulfonylurea therapy fails to diminish insulin resistance in type I-diabetic subjects.
Keller U; Müller R; Berger W
Horm Metab Res; 1986 Sep; 18(9):599-603. PubMed ID: 2946637
[TBL] [Abstract][Full Text] [Related]
19. Relative contribution of glycogen synthesis and glycolysis to insulin-mediated glucose uptake. A dose-response euglycemic clamp study in normal and diabetic rats.
Rossetti L; Giaccari A
J Clin Invest; 1990 Jun; 85(6):1785-92. PubMed ID: 2189891
[TBL] [Abstract][Full Text] [Related]
20. Defective acute insulin secretion in diabetics. Differences between normal weight and obese subjects.
Vague P; Ramahandridona G; Vialettes B; Raymond JP; Vague J
Diabete Metab; 1978 Dec; 4(4):261-5. PubMed ID: 729892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
